After achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of ...

Envoy Medical's global patent portfolio now consists of: 35 pending applications (26 foreign and 9 U.S.) The foreign patent ...

With a trillion-dollar market cap and a wildly successful GLP-1 portfolio, Eli Lilly isn’t resting on its laurels. At the ...

Agreement follows 18 months of validated market demand for the companies' rapid on-farm avian influenza test and adds ...

STAR Apollo™ Mapping System identifies atrial fibrillation (AF) drivers based on the fundamental electrophysiological ...

Looking for a biopharma job in Pennsylvania? Job postings in the state tripled year over year on BioSpace. These nine companies are hiring now.

As pharmas reshore manufacturing, they’re squaring off with each other to find the right personnel to staff up their plants. That task is challenging given the limited talent pool, difficulty filling ...

The mid-stage readout is one link in a chain of catalysts that analysts were watching for this year from Roche’s metabolic pipeline, which features assets from the $2.7 billion acquisition of Carmot ...

Jaguar was also granted a waiver of the fee by the Center for Veterinary Medicine of the FDA for the 2027 fiscal year for ...

Citing the urgent unmet need for patients with advanced biliary tract cancer, Compass Therapeutics will continue to seek an approval path for its drug after the FDA recommended the biotech conduct a ...

Award supports development of automated clinical consistency checking to strengthen safety monitoring across trial data ...

With more than 25 companies debuting on the public markets, 2026 has recorded the highest number of biotech IPOs since 2021. Now, four companies—including Iambic Therapeutics and ADARx Pharmaceuticals ...